Adult Stem Cells for Orthopedic and Spine Repair
The first stem cell products have launched and pipelines are expanding in what could be a billion-dollar market.
You may also be interested in...
A brief discussion of a few new companies in the spine and orthopedic surgery market that presented at Medtech Insight and Windhover Information's IN SPINE & ORTHOPEDICS conference in Las Vegas, December 2006.
The science of stem cells is progressing, slowly but surely, towards the ultimate goal of creating a therapeutic. The challenge is now largely economic: convincing investors that stem cells present a viable business opportunity.
Despite disappointment in its Phase III study, Roche is preparing a new trial of the antisense therapy in patients with a lower disease burden.